ARG |
Ascending ramp of glucose |
AUC |
Area under the curve |
CHG |
Constant high-glucose concentration protocol |
DGSCS |
Dynamic glucose-stimulated C-peptide secretion |
DGSIS |
Dynamic glucose-stimulated insulin secretion |
DPG |
Double pulse of glucose protocol |
GPPs |
Glucose perifusion protocols |
HG |
High glucose |
HLSC |
Human liver stem-cell |
HLSC-ILS |
Human liver stem-cell-derived islet-like structures |
IEQ |
Islet equivalent |
KCl |
Potassium chloride |
LG |
Low glucose |
MPS |
Microfluidic perifusion system |
PIs |
Pancreatic islets |
STZ |
Streptozotocin |
SCID |
Severe combined immunodeficient mice |
SGSIS |
Static glucose-stimulated insulin secretion |
SPGP |
Single pulse of glucose and potassium protocol |
T2DM |
Type 2 diabetes mellitus |
ARG |
Ascending ramp of glucose |
AUC |
Area under the curve |
CHG |
Constant high-glucose concentration protocol |
DGSCS |
Dynamic glucose-stimulated C-peptide secretion |
DGSIS |
Dynamic glucose-stimulated insulin secretion |
DPG |
Double pulse of glucose protocol |
GPPs |
Glucose perifusion protocols |
HG |
High glucose |
HLSC |
Human liver stem-cell |
HLSC-ILS |
Human liver stem-cell-derived islet-like structures |
IEQ |
Islet equivalent |
KCl |
Potassium chloride |
LG |
Low glucose |
MPS |
Microfluidic perifusion system |
PIs |
Pancreatic islets |
STZ |
Streptozotocin |
SCID |
Severe combined immunodeficient mice |
SGSIS |
Static glucose-stimulated insulin secretion |
SPGP |
Single pulse of glucose and potassium protocol |
T2DM |
Type 2 diabetes mellitus |